International Journal of Radiation Oncology Biology Physics

Article	Citations
Issue Highlights page	254
Careful with the Cauda	146
Managing the Minefields in Optimal Treatment	137
Issue Highlights page	136
Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer	135
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study	135
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC	127
Does Operability Status Influence Outcomes in Patients with T4 Larynx Cancer Undergoing Larynx Preservation?	120
In Reply to Onal et al	106
The R's of Radiation Therapy: Do We Need More or Do We Move On?	103
The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations	97
A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Red	97
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	94
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	88
A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors	85
Organ at Risk Dose Constraints in Stereotactic Ablative Radiotherapy: A Systematic Review of Active Clinical Trials	81
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	78
Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial	73
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	72
Synthetic CT Generation From Multi-Sequence MR Images for Head and Neck MRI-Only Radiotherapy via Cycle-Consistent Generative Adversarial Network	70
MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion	69
Wireless Device for Adaptive Planning Based Upon Thermoacoustic Range Estimates ― Design and Benchtop Validation	68
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	67
Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma Patients	66
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	65

Withdrawn	65
Stereotactic Ablative Radiotherapy for the Treatment of Pancreatic Metastases from Renal Cell Carcinoma	64
Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	64
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	63
Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy	62
Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy	60
Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors	60
Vertex Position Optimization for LATTICE Therapy	58
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	56
Rapid Reinstatement of Cancer Care after Hurricane Ian	56
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	55
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	55
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	55
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	54
Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy	54
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	53
Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity	53
Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation	52
1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 Fractions	52
Dosimetric Comparison and Clinical Implications of Dose Calculation Algorithms for Stereotactic Body Radiation Therapy in Spine Metastases	50
The Role and Mechanism of Ferroptosis Mediated by METTL3-m6A Modification in Regulating Radioresistance of Esophageal Cancer	49
Withdrawn	49
Dosimetric Outcomes for Multiple Intracranial Targets Treated Simultaneously With LINAC-Based Stereotactic Radiosurgery as Dictated by Beam Energy, MLC Leaf Width, and Prescribed Isodose Level	48
The Universality of Parallel Increasing Quantitative Nodal Burden and Mortality Across Solid Cancers	47
Comparative In Silico Analysis of Intensity Modulated Scanning Beam Proton Therapy (IMPT) and Volumetric Modulated Arc Photon Radiotherapy (VMAT) for the Post-Operative Treatment of Prostate Cancer	46
A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation Damage	46
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT Data	46
Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	46
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	46
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys	44
The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer	44
Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical Trial	44
Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade	43
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma	43
NTCP-Driven Comparison of Proton Versus VMAT Approaches for Reducing Hematologic and Gastrointestinal Toxicities in Anal Cancer Patients Receiving Definitive Chemoradiation	43
Is a Deep Learning Based Segmentation Model Trained on planning CTs Transferable for Segmentation of Organs at Risk in Replanning CTs?	43
Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103	42
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma	42
A Practical Method to Prolong Expiratory Breath Holds for Abdominal Stereotactic Body Radiotherapy	42
SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System	41
Combination Treatment of Irradiation and Tumor Treating Fields for Human Glioblastoma Cells	41
Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate Cancer	41
DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring Guidelines	41
Predicting Recurrent Patterns After Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Patients With High-Grade Gliomas Incorporating Multimodal Magnetic Resonance Imaging and Molecular Biomar	41
First Application of Predictive Model to Assist Adaptive Proton Therapy	40
Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors	39
Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy	39
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial	39
Withdrawn	39
Population-Based Study on the Association Between Autoimmune Disease and Lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea	39

Prospective Evaluation of Locoregional Control in Oral Cavity Squamous Cell Carcinoma with Infratemporal Fossa Involvement Treated with Surgery and Adjuvant Concurrent Chemoradiotherapy	38
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy	38
Prospective and Comprehensive Characterization of an Inpatient Radiation Oncology Consult Service: Examining Interdisciplinary Coordination of Palliative Radiation Access and Receipt	38
A Randomized Controlled Phase Ⅱ Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer	38
Stereotactic Body Radiation Therapy for Large Volume Solid Tumor Spinal Metastases Involving Three or More Contiguous Vertebral Levels	38
Irradiation Dose to the Swallowing Muscles Impacts Nutritional Status in Head and Neck Cancer Patients: The Prospective Randomized HEADNUT Trial	38
Survival Outcomes in Primary Angiosarcoma of the Head and Neck: A Systematic Review and Meta-Analysis	37
Anticipating Poor Outcomes: A Prognostic Machine Learning Model of Unplanned Visits to the Emergency Department for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multi-Fac	37
Withdrawn	37
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis	37
Financial Toxicity in Patients with Gynecologic Cancer Undergoing Brachytherapy	36
Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review	36
Machine Learning Algorithm Prospectively Predicts Survival for High-Risk Patients Undergoing Radiotherapy: A Survival Analysis of SHIELD-RT	36
Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy	36
The Effect of Package Time on Locally Advanced Oral Cavity Cancer Outcomes	36
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain	36
Pivotal Roles of Tumor-Draining Lymph Nodes in the Abscopal Effect from Combined Immunotherapy and Radiotherapy	35
Hyperfractionated and Accelerated Reirradiation for Angiosarcoma Following Breast-Conserving Therapy: Long-Term Clinical Outcomes	35
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation	35
Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy	35
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma	35
Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era	35
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies	35
Frameless Multisession Radiosurgery for Symptomatic Circumscribed Choroidal Hemangioma	34
Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma	34
Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia after Radiotherapy in Breast Cancer	34
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy	34
Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas	34
Magnetic Resonance Guided Stereotactic Ablative Radiation Therapy vs. Chemoradiation for Borderline and Locally Advanced Pancreatic Cancer: Single Institution Overall Survival Comparison	34
Non-Invasive SRS Ablation for Cardiac Arrhythmias in the Era of Value-Based Healthcare Delivery	34
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors	34
A Phase II Trial of PD-1 Inhibitors Combined With Multisite Radiotherapy and GM-CSF (PRaG Regimen) for the Treatment of Chemo-Refractory Metastatic Solid Tumors	33
A Japanese Multi-Institutional Phase II Study of Moderate Hypofractionated Intensity-Modulated Radiotherapy With Image-Guided Technique for Prostate Cancer	33
Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma	33
Insurance Approval for Proton Therapy in Patients With Thoracic Malignancies: An Experience From a Cost-Neutral Payor Environment	33
A Novel Multi-Channel Tandem Applicator for Direction Modulated Brachytherapy	33
Incidence, Treatment and Clinical Outcomes for Lacrimal Gland Cancer	33
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial	33
Trends in Private Equity Involvement in Oncology Practices in the United States	32
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization	32
Individual Patient Level Meta-Analysis of Prospective Trials Studying Metastasis-Directed Therapy for Metachronous Oligometastatic Prostate Cancer	32
Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation	32
Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large Tumor	32
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors	32
Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis	31
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy	31
Accelerated Partial Breast Irradiation (APBI) Using Five Daily Fractions: A Prospective, Phase II, Multi-Center Trial of Cosmetic Outcomes and Toxicity: Final Results	31
Geometric and Dosimetric Evaluation of Using a Novel Tongue Positioning Device to Reduce Tongue Motions during Radiation Therapy for Head and Neck Cancer	31
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy	31
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients	31
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer	31
A Radiation Therapy Contouring Atlas for Delineation of the Level I-II Axilla in the Prone Position	30
Clinical Correlates of Portal Venous or Superior Mesenteric Vein Thrombosis Following Neoadjuvant Therapy with Dose Escalated Radiation for Borderline Resectable or Locally Advanced Pancreatic Adenoca	30
Withdrawn	30
Site-Specific Education Using Digital Media to Improve Patients’ Understanding of the Radiotherapy Trajectory: An Interventional Study	30
Contralateral Nodal Relapse (CLNR) in Well Lateralized Oral Cavity Cancer Treated Ipsilaterally with Surgery and Adjuvant Radiotherapy with or without Concurrent Chemotherapy: A Retrospective Audit	30
HyperArc Planning for Benign Intracranial Pathologies: A Prospective Analysis on Plan Quality, Delivery, Control and Toxicity	30
Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate Marker	30
Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network	29
IL-1β+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal Effect	29
Real-World Data for Integration Strategy of Radiotherapy (RT) With Immunotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)	29
Maximization of Peak-to-Valley Dose Ratio and Normal-Tissue Survival Fraction for Proton Minibeam Radiation Therapy	29
Recurrence Dynamics After Complete Resection and Adjuvant Chemotherapy in Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer	29
Validation of Lexicographic Optimization-Based Planning for Brain Metastases Radiosurgery with Coplanar Arcs	29
Clinical Outcomes After Trimodality Therapy With Dose-Escalated Neoadjuvant Intensity-Modulated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer	29
Real-World Outcomes of Chemoradiation and Consolidative Durvalumab in Unresectable Stage III Non-Small-Cell Lung Cancer — A Systematic Review	29
Re-Evaluating Surgery and Re-Irradiation for Locally Recurrent Pediatric Ependymoma — a Multi-Institutional Study	28
90-Day Hospitalization as a Surrogate for Overall Survival in Hepatocellular Carcinoma (HCC) Patients Treated With Magnetic Resonance-Guided Liver Stereotactic Body Radiation Therapy: Results of a Sin	28
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning	28
Retrospective Analysis of Proton Beam Therapy for Postoperative Locally Recurrent Rectal Cancer	28
Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer Radiotherapy	28
Predictive Ability of Delta Radiomic Texture Features (DRTF) Extracted from Liver Patients Treated With Magnetic Resonance Guided Stereotactic Body Radiotherapy (MRgSBRT)	28
De-Escalated Radiotherapy for Advanced Stage Wilms Tumor: A Single-Center Experience	28
Guided Deep Learning Auto-Correction of Suboptimal Auto-Segmentation of Complex Structures for MRI-Guided Adaptive Radiotherapy	28
Balancing Quality and Efficiency of Head and Neck Contour Revision for Online Adaptive Radiotherapy	28
Prevalence and Functional Impact of Vertigo among Long Term Survivors of Head and Neck Cancer	27
Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease	27
Association of Gut Microbiome Characteristics With the Late Gastrointestinal Toxicities After Pelvic Receiving Radiation Treatment for Cervical, Vaginal, and Anal Cancers	27
Initial Experience with the Commercial Electron FLASH Research Extension	27
Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results	27

Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria	27
Withdrawn	26
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St	26
The Dutch Initiative for the Model-Based Selection of Patients for Proton Therapy – A Federated Learning IT Infrastructure	26
Evaluating Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) Treatment Effect on Neurocognitive Function (NCF): Secondary Analysis of NRG-CC001	26
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	26
Methylome Analysis of Rare Sinonasal Malignancies: Novel Venues for Clinical Applications	26
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)	26
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer	26
Intraoral Gavage of Second-Generation Probiotic Lactobacillus Reuteri Releasing IFN-β (LR-IFN-β) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiation (WAI)	26
MC1635: Randomized Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast After Breast Conserving Surgery	25
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy	25
Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients wi	25
Clinical Outcomes in cN+M0 Bladder Cancer Patients: Can Bladder be Spared?	25
Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema	25
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database	24
“Standard” Fractionation for Breast Cancer is No Longer Standard	24
Impact of a Head and Neck Cancer Chemoradiation (HNC CRT) Nurse Practitioner (NP) on Patient Outcomes	24
Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer	24
Atypical Nodal Involvement From an Atypical Meningioma	24
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule	24
In Regard to Hammer et al.	24
In Regard to Wages et al and Leite et al	24
In Reply to Goyal and Madan	23
Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer	23
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma	23
Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and Evaluation	23
Rays Over Knife	23
Primary Mediastinal B-Cell Lymphoma: The Role of Consolidative Radiation for a “Terrible” Lymphoma	23
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases	23
The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study	23
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial	23
In Reply to Tsoutsou	23
Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion—An ASTRO SCAROP-ADROP-ARRO Collaboration	23
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey	23
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine	23
Doing Our Best With What We Have (and Know)	23
Meetings page	23
Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?	22
The Association of Genetic Polymorphisms in the TNF-α Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy	22
Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer	22
Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients	22
Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy	22
Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review	22
Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	22
“Big Jolts Like an Electric Shock:” Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer	22
Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction	22
Withdrawn	22
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021	21
Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics	21
Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment	21
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)	21
Performance of Multiparametric MRI and PET Imaging in Identifying and Localizing Locally Radiorecurrent Prostate Cancer in a Phase I/II Trial of Focal Salvage HDR	21
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody	21
Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow	21
External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial	21
Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center	21
Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control	21
Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience	20
Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy	20
Small Animal IMRT Using 3D-Printed Compensators	20
Local Therapy for Oligometastatic Disease—Cart Before the Horse?	20
A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression	20
Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy	20
Identification of Triapine as a Novel Radiosensitizer in Glioblastoma	20
Re-Irradiation in Children with Recurrent Medulloblastoma	20
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma	20
Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy	20
Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by 18F-FAPI PET/CT	20
Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)	20
Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Metastasis- Final Analysis of a Phase II Study	20
A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	20
Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy	20
KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses	20
Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative	20
Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Program's Impact	20
Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy	19
Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis	19
Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma	19
Optimizing Radiation Treatment for Glioblastoma Patients: Contrasting Dosimetric Profiles of HyperArc and Volumetric Arc Therapy	19
Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety	19
A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup	19
Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins	19
The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation	19
Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy	19
Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network	19
Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapy's Environmental Load?	19
Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety	19
Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution	19
Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy	19
Mid-Range Arc Therapy—Enhancing Dosimetric Quality, Robustness and Efficiency for Proton Treatment with Simple Planning	19
Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)	18
Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA	18
A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy	18
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers	18